Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

Michael H Olsen, Kristian Wachtell, Hans Ibsen, Lars Lindholm, Sverre E Kjeldsen, Per Omvik, Markku S Nieminen, Björn Dahlöf, Peter M Okin, Richard B Devereux

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

To investigate whether in-treatment measurements of subclinical organ damage (SOD) assessed by elevated urine albumin/creatinine ratio (UACR) or electrocardiographic left ventricular hypertrophy improved the prediction of the composite cardiovascular endpoint of cardiovascular death, nonfatal myocardial infarction and stroke beyond in-treatment Framingham risk score (FRS).
OriginalsprogEngelsk
TidsskriftInternational Journal of Hypertension
Vol/bind29
Udgave nummer5
Sider (fra-til)997-1004
Antal sider8
ISSN2090-0392
DOI
StatusUdgivet - 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy'. Sammen danner de et unikt fingeraftryk.

Citationsformater